XOMAP Q2 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+568.6% YoY

Gross Profit

$10M89.5% margin

Operating Income

-$10M-90.9% margin

Net Income

$16M144.2% margin

EPS (Diluted)

$1.00

QoQ Revenue Growth

+644.0%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$243M

Total Liabilities

$143M

Stockholders' Equity

$100M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$2M	+568.6%
Gross Profit	$10M	$2M	+513.0%
Operating Income	-$10M	-$6M	-69.2%
Net Income	$16M	-$5M	+396.0%